Takeaway

• Combined “omics” data can be used to direct patients to more personalized standard therapies, position them for trials or identify cases for off-label treatment.
• The integration of multiple data types provides more molecularly guided treatment options to patients with the same tumour type.
• Integrating whole genome and RNA sequencing...